Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Journey Medical (DERM) Gross Profit (2020 - 2025)

Journey Medical's Gross Profit history spans 6 years, with the latest figure at $10.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Gross Profit rose 26.2% year-over-year to $10.0 million, compared with a TTM value of $39.7 million through Dec 2025, up 15.93%, and an annual FY2025 reading of $40.3 million, up 17.69% over the prior year.
  • Gross Profit for Q4 2025 was $10.0 million at Journey Medical, down from $11.3 million in the prior quarter.
  • The five-year high for Gross Profit was $15.1 million in Q1 2022, with the low at $5.6 million in Q4 2022.
  • Average Gross Profit over 5 years is $9.1 million, with a median of $8.9 million recorded in 2022.
  • Biggest YoY gain for Gross Profit was 133.39% in 2023; the steepest drop was 62.13% in 2023.
  • Tracing DERM's Gross Profit over 5 years: stood at $8.0 million in 2021, then plummeted by 30.26% to $5.6 million in 2022, then surged by 133.39% to $13.0 million in 2023, then crashed by 38.97% to $7.9 million in 2024, then rose by 26.2% to $10.0 million in 2025.
  • Per Business Quant, the three most recent readings for DERM's Gross Profit are $10.0 million (Q4 2025), $11.3 million (Q3 2025), and $10.1 million (Q2 2025).